Embryonic alcohol exposure disrupts the ubiquitin-proteasome system

Abstract

Ethanol (EtOH) is a commonly encountered teratogen that can disrupt organ development and lead to fetal alcohol spectrum disorders (FASDs); many mechanisms of developmental toxicity are unknown. Here, we used transcriptomic analysis in an established zebrafish model of embryonic alcohol exposure (EAE) to identify the ubiquitin-proteasome system (UPS) as a critical target of EtOH during development. Surprisingly, EAE alters 20S, 19S, and 11S proteasome gene expression and increases ubiquitylated protein load. EtOH and its metabolite acetaldehyde decrease proteasomal peptidase activity in a cell type–specific manner. Proteasome 20S subunit β 1 ( psmb1 hi2939Tg ) and proteasome 26S subunit, ATPase 6 ( psmc6 hi3593Tg ), genetic KOs define the developmental impact of decreased proteasome function. Importantly, loss of psmb1 or psmc6 results in widespread developmental abnormalities resembling EAE phenotypes, including growth restriction, abnormal craniofacial structure, neurodevelopmental defects, and failed hepatopancreas maturation. Furthermore, pharmacologic inhibition of chymotrypsin-like proteasome activity potentiates the teratogenic effects of EAE on craniofacial structure, the nervous system, and the endoderm. Our studies identify the proteasome as a target of EtOH exposure and signify that UPS disruptions contribute to craniofacial, neurological, and endodermal phenotypes in FASDs.

PSMB2 plays an oncogenic role in glioma and correlates to the immune microenvironment

“…The ubiquitin‒proteasome system consists of ubiquitin (Ub), ubiquitin activating enzymes (E1), ubiquitin ligases (E2), ubiquitin protein ligases (E3), the 26S proteasome, and deubiquitinating enzymes (DUBs) 27 . Protein degradation by the ubiquitin‒proteasome is a cascade process in which ubiquitinated proteins are finally degraded by the 26S proteasome 28 . In glioma cells, tumor suppressor genes are ubiquitin-labeled and degraded by the 26S proteasome 29 .…”

Relationship between the expression of PSMB2 and proliferation and invasion in glioma

“…The ubiquitin-proteasome system consists of ubiquitin (Ub), ubiquitin activating enzymes (E1), ubiquitin ligases (E2), ubiquitin protein ligases (E3), the 26S proteasome, and deubiquitinating enzymes (DUBs) [29] . Protein degradation by the ubiquitin-proteasome is a cascade process in which ubiquitinated proteins are nally degraded by the 26S proteasome [30] . In glioma cells, tumor suppressor genes are ubiquitin-labeled and degraded by the 26S proteasome [31] .…”

PSMB2: A potential immunological and prognostic Signature in glioma

“…The ubiquitin-proteasome system consists of ubiquitin (Ub), ubiquitin activating enzymes (E1), ubiquitin ligases (E2), ubiquitin protein ligases (E3), the 26S proteasome, and deubiquitinating enzymes (DUBs) [29] . Protein degradation by the ubiquitin-proteasome is a cascade process in which ubiquitinated proteins are nally degraded by the 26S proteasome [30] . In glioma cells, tumor suppressor genes are ubiquitinlabeled and degraded by the 26S proteasome [31] .…”